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Unfortunately, the original version of this article [1]
contained an error within Fig. 5. For testing Sema4D
protein expression in PaTu8988 cells with/out SAHA
treatment, the protein samples of Fig. 2D were re-tested
by Western blot assay using Sema4D antibody (Fig. 5E).
The correct version of Fig. 5E can be found below. This
does not alter the conclusion of the result.* Correspondence: dryangbosz@163.com; caocong@suda.edu.cn
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Fig. 5 PaTu8988 cells were incubated with SAHA at indicated
dosage for 48 hours, the protein expressions of Sema4D and tubulin
were tested by Western blots. Experiments in this figure were
repeated three times, and similar results were obtained. e SAHA
suppresses PaTu8988 cell vasculogenic mimicry (VM)
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